The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma

Eur J Ophthalmol. 2010 Jan-Feb;20(1):251; author reply 252. doi: 10.1177/112067211002000144.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage*
  • Anterior Chamber / drug effects
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Glaucoma, Neovascular / physiopathology
  • Glaucoma, Neovascular / surgery*
  • Humans
  • Intraocular Pressure / physiology
  • Iris / blood supply*
  • Neovascularization, Pathologic / drug therapy*
  • Trabecular Meshwork / surgery*
  • Trabeculectomy*
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab